Exchange: NASDAQ·Updated 07:30 PM EDT
ACIU logo

ACIU AC Immune SA

$2.86
$0.07
(2.39%)
Today
Closed $2.86
$0.00
(0.00%)
After Hours
EarningsNov 4
Mkt Cap$291.07M
Vol155,628.00

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eliseev on February 13, 2003 and is headquartered in Lausanne, Switzerland.
42

Bearish Sentiment

How do you feel about ACIU?

Advertisement|Remove ads.